Brokerages Set Tenet Healthcare Corporation (NYSE:THC) PT at $231.81

Tenet Healthcare Corporation (NYSE:THC) has received a consensus recommendation of “Moderate Buy” from the twenty-one ratings firms that are covering the firm, MarketBeat reports. Four research analysts have rated the stock with a hold recommendation, sixteen have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $231.8125.

A number of brokerages recently issued reports on THC. Weiss Ratings raised Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, December 29th. The Goldman Sachs Group initiated coverage on shares of Tenet Healthcare in a research report on Tuesday, October 14th. They issued a “buy” rating and a $224.00 target price on the stock. Guggenheim boosted their price target on shares of Tenet Healthcare from $238.00 to $257.00 and gave the company a “buy” rating in a research report on Tuesday, December 2nd. Royal Bank Of Canada lifted their target price on Tenet Healthcare from $230.00 to $252.00 and gave the stock an “outperform” rating in a research report on Thursday, October 30th. Finally, Truist Financial reissued a “buy” rating and issued a $240.00 target price (up from $225.00) on shares of Tenet Healthcare in a research report on Monday, November 3rd.

Insider Buying and Selling at Tenet Healthcare

In related news, Director Richard W. Fisher sold 2,500 shares of the company’s stock in a transaction on Wednesday, October 29th. The shares were sold at an average price of $208.43, for a total value of $521,075.00. Following the completion of the sale, the director owned 8,792 shares in the company, valued at $1,832,516.56. This represents a 22.14% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Tammy Romo sold 15,099 shares of the firm’s stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $200.81, for a total transaction of $3,032,030.19. Following the transaction, the director directly owned 47,267 shares in the company, valued at $9,491,686.27. The trade was a 24.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 45,500 shares of company stock valued at $9,247,071. Insiders own 0.81% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently modified their holdings of THC. Triumph Capital Management purchased a new position in Tenet Healthcare in the third quarter valued at about $25,000. William B. Walkup & Associates Inc. purchased a new position in Tenet Healthcare in the 3rd quarter valued at approximately $32,000. Chung Wu Investment Group LLC acquired a new position in Tenet Healthcare during the second quarter worth $35,000. Canada Pension Plan Investment Board acquired a new stake in Tenet Healthcare in the second quarter valued at $35,000. Finally, Westside Investment Management Inc. raised its stake in shares of Tenet Healthcare by 100.0% during the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after buying an additional 96 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Price Performance

Shares of THC opened at $208.18 on Friday. The company has a current ratio of 1.71, a quick ratio of 1.64 and a debt-to-equity ratio of 2.27. The firm’s fifty day simple moving average is $202.55 and its 200-day simple moving average is $189.40. The firm has a market capitalization of $18.30 billion, a price-to-earnings ratio of 14.27, a PEG ratio of 0.88 and a beta of 1.41. Tenet Healthcare has a twelve month low of $109.82 and a twelve month high of $222.82.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Tuesday, October 28th. The company reported $3.70 earnings per share for the quarter, beating analysts’ consensus estimates of $3.33 by $0.37. The company had revenue of $5.29 billion for the quarter, compared to analysts’ expectations of $5.26 billion. Tenet Healthcare had a return on equity of 25.11% and a net margin of 6.49%.Tenet Healthcare’s quarterly revenue was up 3.2% on a year-over-year basis. During the same period last year, the firm earned $2.93 earnings per share. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. Equities analysts forecast that Tenet Healthcare will post 12.24 EPS for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.